| Literature DB >> 26670137 |
Adanze O Asinobi1,2, Adebowale D Ademola3,4, Clement A Okolo5,6, Joseph O Yaria7.
Abstract
BACKGROUND: Reports on the histopathology of childhood nephrotic syndrome (NS) had emanated from our Centre since the 1960s and by the late 1980s and early 1990s, a change was observed and reported. Taking into consideration the worldwide changing trend in the histopathology of the NS and our Unit policy change in the indications for renal biopsy, a change was envisaged. We therefore evaluated the current histologic pattern of childhood NS in Ibadan with the view to highlighting any variations from the past and comparing the findings with regional and global trends.Entities:
Mesh:
Year: 2015 PMID: 26670137 PMCID: PMC4681037 DOI: 10.1186/s12882-015-0208-0
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Overall histologic pattern in the present study
Fig. 2Distribution of Primary and Secondary cases in the Post-steroid treatment era (2006–2013)
Fig. 3This is a photomicrograph of focal segmental glomerulosclerosis (FSGS). An area of collagenous sclerosis runs across the middle of this glomerulus
Comparison of idiopathic steroid resistant nephrotic syndrome
| Bonilla-Felix et al 1999 [ | Gulati et al. 2006 [ | Seif et al. 2013 [ | Mubarak et al. 2012 [ | Olowu et al. 2010 [ | Obiagwu et al. 2014 [ | Present study | |
|---|---|---|---|---|---|---|---|
| Location | USA | India | Egypt | Pakistan | Ile Ife | Kano | Ibadan |
| Period of Study | 1987–1997 | 1990–1996 | 2005–2011 | 2009–2011 | 2001–2007 | - | 2006–2013 |
| No. of Subjects | 152 | 33 | 53 | 147 | 19 | 11 | 30 |
| Mean age in years | 5.3 | 5.7 | 6.7 | 7 | 8 | 8 | 9 |
| MPGN | 5.0 % | 1.6 % | 7.5 % | 4.8 % | 43.5 % | 9.1 % | 27 % |
| FSGS | 31 % | 58.8 % | 30.2 % | 38.7 % | 39.1 % | 54.5 % | 60 % |
| MCN | 35 % | 17.6 % | 24.5 % | 23.1 % | 4.35 % | 27.3 % | 3 % |
| MesPGN | 25 % | 17.6 % | 1.9 % | 10.2 % | 8.7 % | - | - |
Association of Clinical and Laboratory Features with Histologic Types
| FSGS | MPGN | MCD | OTHERS | P | |
|---|---|---|---|---|---|
| AGE (YEARS) | 9.5 (3.8) | 8.7 (3.4) | 7.5 (3.2) | 9.8 (3.0) | 0.37 |
| *PCV (%) | 28.1 (7.3) | 34.6 (5.0) | 38.3 (4.1) | 27.2 (10.5) | 0.01 |
| CR (MG/DL) | 2.0 (1.4) | 0.9 (0.4) | 0.7 (0.4) | 3.7 (4.1) | 0.05 |
| CHOL (MG/DL) | 416.1 (165.9) | 329.9 (147.7) | 405.2 (246.7) | 437.0 (162.6) | 0.77 |
| TG (MG/DL) | 302.5 (171.8) | 260.0 (233.0) | 276.4 (154.3) | 300.0 (135.4) | 0.97 |
| HDL (MG/DL) | 50.7 (14.8) | 47.3 (10.7) | 51.0 (17.3) | 60.3 (40.9) | 0.82 |
| LDL (MG/DL) | 278.8 (170.2) | 187.8 (96.3) | 277.0 (199.0) | 292.6 (115.0) | 0.62 |
| DURATION IN WEEKS (MEDIAN, IQR) | 2 (1–4) | 2 (1–4) | 8 (2–48) | 3 (2–8) | 0.744 |
*PCV - The only association of significance
Comparison with other studies in our environment and globally
| Hendrickse (1972) [ | ISKDC Study (1978) [ | Abdurrahman et al. (1990) [ | Asinobi et al. (1999) [ | Present study | |
|---|---|---|---|---|---|
| Location | Ibadan | Multinational | Zaria | Ibadan | Ibadan |
| Number | 63 | 521 | 99 | 41 | 78 |
| Mean age (year) | No data | - | 5.8 | 7.9 | 9.5 |
| Quartan malarial nephropathy | 51 (81.0) | - | 20 (20.4) | - | _ |
| Mes.PGN | 5 (7.9) | (12) 2.3 | - | - | - |
| MPGN | - | (39) 7.5 | 25 (25.5) | 21 (51.2) | 16 (20.5) |
| MCD | 5 (7.9) | (398) 76.4 | 9 (9.2) | 4 (9.8) | 15 (19.2) |
| Membranous | - | (8) 1.5 | 2 (2.0) | 4 (9.8) | 1 (1.3) |
| Proliferative GN | - | - | 19 (19.4) | 2 (4.9) | 8 (10.3) |
| Chronic GN | - | - | - | 1 (2.4) | 3 (3.8) |
| FSGS | 1 (1.6) | (36) 6.9 | 2 (2.0) | 2 (4.9) | 31 (39.8) |
| Others | 1 (1.6) | (28) 5.4 | 21 (21.5) | 7 (17.0) | 4 (5.1) |
| Total | 63 (100) | 521 (100) | 99 (100) | 41 (100) | 78 (100) |
a,b,c,d referenced studies above were Pre-treatment biopsies while e, was majorly Post-treatment